Is mammography adequate for screening women with inherited BRCA mutations and low breast density?
نویسندگان
چکیده
BACKGROUND Several observational studies have shown that magnetic resonance imaging (MRI) is significantly more sensitive than mammography for screening women over age 25 at high risk for hereditary breast cancer; however, MRI is more costly and less specific than mammography. We sought to determine the extent to which the low sensitivity of mammography is due to greater breast density. METHODS Breast density was evaluated for all patients on a high-risk screening study who were diagnosed with breast cancer between November 1997 and July 2006. Density was measured in two ways: qualitatively using the four categories characterized by the Breast Imaging Reporting and Data System and quantitatively using a computer-aided technique and classified as (a) 50% density. Comparison of sensitivity of mammography (and MRI) for each individual density category and after combining the highest two and lowest two density categories was done using Fisher's exact test. RESULTS A total of 46 breast cancers [15 ductal carcinoma in situ (DCIS) and 31 invasive] were diagnosed in 45 women (42 with BRCA mutations). Mean age was 48.3 (range, 32-68) years. Overall, sensitivity of mammography versus MRI was 20% versus 87% for DCIS and 26% versus 90% for invasive cancer. There was a trend towards greater mammographic sensitivity for invasive cancer in women with fattier breasts compared with those with greater breast density (37-43% versus 8-12%; P = 0.1), but this trend was not seen for DCIS. CONCLUSION It is necessary to add MRI to mammography for screening women with BRCA mutations even if their breast density is low.
منابع مشابه
تاثیر درمان جایگزینی با هورمون (HRT) بر حساسیت ماموگرافی غربالگری در خانم های یائسه
Background and purpose:The risk of developing breast cancer during the liftime of females is 12.5% (about 1 in 8). Ïn addition hormone replacement therapy is part of the preventive measure in women at their menopausal period. Studies have revealed that screening mammography changes with age, mammographyic density and family history of breast cancer. This study was designed to evaluate the bre...
متن کاملThe American Cancer Society guidelines for breast screening with magnetic resonance imaging: an argument for genetic testing.
BACKGROUND The American Cancer Society (ACS) guidelines for screening with breast magnetic resonance imaging (MRI) recommend MRI for women who have a lifetime risk > or = 20% of developing breast cancer. Genetic testing for breast cancer gene (BRCA) mutations is offered to women who have a risk > or = 10% of carrying a mutation. The objectives of the current study were 1) to identify the number...
متن کاملبررسی نقش سونوگرافی تکمیلی در تشخیص سرطان پستان
Introduction & Objective: The breast cancer is the most common malignancy in women and in recent years it is seen in younger ages. Because of dense breast tissue in these ages, the mammography sensitivity for breast cancer detection is reduced, so high quality ultrasonography (US) as a combined screening method is effective. The aim of this study is the evaluation of the mammographic finding ...
متن کاملUtilization of magnetic resonance imaging in breast cancer screening.
Early detection of malignancy through breast cancer screening has contributed significantly to the decline in cancer-related mortality1. The U.S. Preventive Services Task Force recently reaffirmed its 2009 stance to begin mammography—the primary screening modality—starting from age 50 and continuing until age 742. However, that recommendation applies primarily to women at “average risk” for dev...
متن کاملMutation Screening of BRCA Genes in 10 Iranian Males with Breast Cancer
Male breast cancer is a rare disease with an increasing trend. Due to limited information especially about the genetic basis of the disease in Iran and the lower age of its onset, the disease requires more attention. The aim of this study was to screen the male patients with breast cancer for BRCA mutations as well as tissue markers of estrogen receptor (ER), progesterone receptor (PR), human e...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
دوره 17 3 شماره
صفحات -
تاریخ انتشار 2008